abstract |
The present invention relates to novel trifiuoromethyl-oxadiazole derivatives of the formula (I) and their pharmaceutical acceptable salts, pharmaceutical compositions thereof, pharmaceutical combinations thereof, and in particular neurodegeneration through inhibition of HDAC4, muscle atrophy or diabetes / metabolism ≪ / RTI > syndrome. (I) In this formula, all variables are as defined in the specification. |